Market cap
$4.6m
End-of-day close multiplied by current shares on issue.
A NZ$4.1m discontinued-operation gain funded a balance-sheet reset, but continuing operations stayed loss-making on a sharply lower revenue base.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$4.6m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.00
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
1.52x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY26 vs HY25
Revenue
$2.6m
-31.7% ↓ vs $3.7m
EBITDA
−$0.83m
+53.8% ↑ vs −$1.8m
Net profit after tax
$3.2m
+233.3% ↑ vs −$2.4m
Net cash inflow from operating activities
−$1m
+4.6% ↑ vs −$1m
Profit before tax
−$0.9m
+62.5% ↑ vs −$2.4m
Cash and cash equivalents
$2.2m
+36.8% ↑ vs $1.6m
Total assets
$6.6m
-65.3% ↓ vs $19m
What changed
Continuing operations remain loss-making: PBT was –NZ$0.9m versus –NZ$2.4m, a +62.9% improvement, on revenue of NZ$2.554m down 31.7% from NZ$3.738m. PBT is the cleaner read on operating performance because the effective tax rate is 0.0% in both periods and the divergence between PBT and NPAT growth (–169.5pp) is explained by the disposal.
The disposal also reshaped the balance sheet. Total assets fell 65.3% to NZ$6.6m — Annolyse's historical baseline classifies this as an unprecedented low against a four-period mean of NZ$29.9m and prior range NZ$19.0m–NZ$46.2m. Gross borrowings dropped 85.6% to NZ$2.25m, inventory cleared from NZ$13.5m to NZ$2.4m, and equity rebuilt to NZ$3.055m from NZ$1.272m.
What matters
The NZ$4.121m disposal gain accounts for more than the entire reported profit; continuing operations lost NZ$0.902m on revenue that fell 31.7%. This matters because investors comparing headline net profit to the prior period would see a 232.4% swing that does not reflect any improvement in the underlying trading business.
The business is materially smaller and simpler. Total assets at NZ$6.6m are unprecedented in the four-period history, with inventory days collapsing from 654.8 to 173.7 (Annolyse's historical baseline shows a prior mean of 1,368 days) and net debt now effectively nil at NZ$0.024m versus NZ$14.0m. The disposal cleaned the balance sheet, but it also removed the asset and revenue base the company previously stood on.
Cost discipline is real but on a shrinking top line. EBITDA loss narrowed 53.8% to –NZ$0.827m and EBITDA margin of –32.4% is the best in Annolyse's four-period baseline (mean –76.6%). The improvement is genuine, but the operating loss narrowed while revenue fell 31.7%, so the read is cost-out rather than scale-up.
Expectations
HY26 reported revenue annualises to roughly NZ$5.1m, leaving a meaningful gap to the target — the implied required step-up is a 27.3% lift on the annualised base, and H1 has just declined 31.7% year-on-year. Management cites 21% growth in continuing-operations gross revenue versus prior, but the statutory revenue line shows a decline, so the framing depends on which baseline is used.
The supplied second-half-shape context (HY25 at 50.1% of FY25 revenue) implies no meaningful H2 weighting historically, so reaching the NZ$6.5m gross target requires a step-change in H2 trading rather than a normal seasonal lift. The release does not provide a bridge for that step-up.
Quality of result
NPAT depends on a one-off disposal gain; pre-lease free cash flow was –NZ$1.1m, classified as above the historical baseline of –NZ$3.8m but still negative, and FCF/NPAT conversion of –33.8% confirms cash generation did not match the reported profit. Operating cash outflow of –NZ$0.999m is essentially flat versus –NZ$1.047m. Cash conversion of 120.8% sits within Annolyse's historical range (mean 137.3%), so the OCF-to-EBITDA ratio is not flagging deterioration — but it is being measured against a still-negative EBITDA.
The continuing-operations improvement is more durable in direction than in magnitude: the loss narrowed because costs fell faster than revenue, not because revenue grew. Working capital improvements (inventory days down 481, debtor days at 113.7) reflect the disposal of inventory-heavy King Honey rather than tighter trading discipline in the core brand. Until continuing-operations revenue stabilises and turns up, the operating loss trajectory remains the binding constraint on cash.
Unresolved
This briefing cannot assess whether the FY26 NZ$6.5m gross-revenue target is supported by signed orders, channel commitments, or pipeline because no forward-work disclosure is provided.
Chat
Ask follow-up questions about Me Today's HY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Me Today Interim Financial Statements for the 6 months ended 31 December 2025
HY26 / financial reportMe Today Results Announcement
HY26 / results announcementMe Today Results Announcement
HY26 / results releaseMe Today Interim Financial Statements for the six months ended 31 December 2024
HY25 / financial reportMe Today Results Announcement280225
HY25 / results announcementMe Today Results Announcement280225
HY25 / results releaseFinancial Statements
FY25 / financial reportFinancial Statements - Market Announcement
FY25 / results releaseAnnual Meeting Results
HY26 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 169.5pp.
Leverage and balance-sheet risk
Net debt / EBITDA is -0.03x, +7.79x versus the prior comparable period.
Revenue growth context
Revenue growth was -31.7% for this reporting period.
Cash conversion quality
This result converted 120.8% of EBITDA to operating cash flow, +62.3pp versus the prior comparable period.
Get the next Me Today briefing and related NZX reporting-season updates by email.